Samsung Biologics

Samsung Biologics is a manufacturer and distributor of biological products and provides laboratory testing services for the healthcare industry. Read more

John Rim's photo - CEO of Samsung Biologics

CEO

John Rim

CEO Approval Rating

84/100

Founded:

2011

Status:

PublicIndependent CompanyKorea Exchange207940

Annual Revenue
Employees
Headquarters

SAMSUNG BIOLOGICS TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Sandoz is Samsung Biologics's #1 rival. Sandoz is a Private company that was founded in Holzkirchen, Bavaria in 1886. Sandoz competes in the Pharmaceuticals field. Sandoz has 23,910 more employees vs. Samsung Biologics.

Celltrion is perceived as one of Samsung Biologics's biggest rivals. Celltrion was founded in 2002, and is headquartered in Incheon, Gyeonggido. Like Samsung Biologics, Celltrion also competes in the Biotechnology sector. Celltrion generates $233.8M more revenue vs. Samsung Biologics.

Dr.Reddy's is a top competitor of Samsung Biologics. Dr.Reddy's is a Public company that was founded in 1984 in Hyderabad, Andhra Pradesh. Like Samsung Biologics, Dr.Reddy's also competes in the Biotechnology space. Compared to Samsung Biologics, Dr.Reddy's has 19,060 more employees.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Sanofi a competitor of Samsung Biologics?

Samsung Biologics Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$740.8M

Samsung Biologics's revenue is the ranked 9th among it's top 10 competitors. The top 10 competitors average 6.7B. Over the last one quarters, Samsung Biologics's revenue has decreased by 0%. Specifically, in Q2 2020's revenue was $256.2M.

Samsung Biologics Acquisitions

No recent acquisitions found related to Samsung Biologics

Samsung Biologics Funding History

No recent funding data found related to Samsung Biologics

Samsung Biologics Investments

No recent investments found related to Samsung Biologics

Samsung Biologics News

June 1, 2021Biospectrum Asia

Samsung Biologics strengthens mRNA vaccine manufacturing services in Korea

Adding mRNA vaccine DS production capability to its existing facility by the first half of 2022... See more »
May 26, 2021Biospectrum Asia

Korea's Samsung Biologics to provide fill-finish manufacturing for Moderna COVID-19 vaccine

Moderna and Samsung Biologics, a leading global CDMO providing a fully integrated end-to-end contract... See more »
May 24, 2021Benzinga

Moderna, Samsung Biologics Ink Fill-Finish Pact For COVID-19 Shots In South Korea

Moderna Inc (NASDAQ: MRNA) has inked a deal with South Korean CDMO Samsung Biologics for fill-finish ... See more »
May 24, 2021MarketScreener

Samsung BioLogics shares ease after jumping on vaccine deal

(marketscreener.com) SEOUL -Samsung BioLogics' shares ended lower on Monday, after rising as much as ... See more »
May 24, 2021Australian Manufacturing

Samsung Biologics to manufacture Moderna's COVID-19 vaccine in South Korea

Global biotechnology company Moderna has inked a manufacturing services and supply agreement with Sam... See more »
May 22, 2021Markets Insider

Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna's COVID-19 Vaccine

CAMBRIDGE, Mass. and INCHEON, South Korea, May 22, 2021 /PRNewswire/ -- Moderna (Nasdaq: MRNA), a bio... See more »
April 28, 2021The Korea Bizwire

Samsung Biologics Q1 Net Up 66.4 pct on Increased Sales

SEOUL, April 28 (Korea Bizwire) - Samsung Biologics, a biopharmaceutical unit of South Korea's top co... See more »

Samsung Biologics Press Releases

January 27, 2021StreetInsider

Samsung Biologics, National OncoVenture, and Eutilex Obtain IND Approval from FDA

INCHEON, South Korea, Jan. 26, 2021 /PRNewswire/ --Â Samsung Biologics (KRX: 207940.KS) announced ano... See more »
January 26, 2021StreetInsider

Samsung Biologics Reports 66% Increase in 2020 Revenue Achieving "1 Trillion Won" Target Sales

INCHEON, South Korea, Jan. 26, 2021 /PRNewswire/ --Â Samsung Biologics (KRX: 207940.KS) reported its ... See more »
December 15, 2020Press Release India

Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management

Business Wire India Veeva Systems (NYSE: VEEV) today announced that Samsung Biologics, an award-winni... See more »
November 4, 2020PR Newswire

Samsung Biologics' Virtual Exhibition Hall earns top industry award for digital creativity and innovation

INCHEON, South Korea, Oct. 4, 2020 /PRNewswire/ -- Samsung Biologics' Virtual Exhibition Hall was rec... See more »
April 22, 2020centralcharts

Samsung Biologics Earnings to Beat Consensus Again, Continues to Sign New Projects with Enhanced Virtual Support

Samsung Biologics Earnings to Beat Consensus Again, Continues to Sign New Projects with Enhanced Virt... See more »
April 8, 2020PR Newswire Asia

Samsung Biologics named Champion in 2020 CMO Leadership Awards

SONGDO, South Korea, April 8, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) announced that it ha... See more »
February 4, 2020StreetInsider

Samsung Biologics Reports 64% Jump in FY19 Earnings, Sees Global Expansion in 2020

INCHEON, South Korea, Feb. 4, 2020 /PRNewswire/ -- Samsung Biologics, a pharmaceutical Contract Manuf... See more »

Samsung Biologics Videos

Social Media

Samsung Biologics Headquarters

300, Songdo bio-daero

Yeonsu-gu, Incheon Gwang'yeogsi21987

82-0-455-3300

Driving Directions »

Trending Companies

Samsung Biologics Summary

ABOUT

Overview

Samsung Biologics is a manufacturer and distributor of biological products and provides laboratory testing services for the healthcare industry. Samsung Biologics was founded in 2011. Samsung Biologics' headquarters is located in Yeonsu-gu, Incheon Gw...

CEO

Samsung Biologics's CEO, John Rim, currently has an approval rating of 84%. Samsung Biologics's primary competitors are Sandoz, Celltrion & Dr.Reddy's.

Frequently Asked Questions about Samsung Biologics

  1. When was Samsung Biologics founded?

    Samsung Biologics was founded in 2011
  2. Who is Samsung Biologics's CEO?

    Samsung Biologics's CEO is John Rim
  3. How much revenue does Samsung Biologics generate?

    Samsung Biologics generates $740.8M in revenue
  4. How much funding does Samsung Biologics have?

    Samsung Biologics has historically raised $0 in funding
  1. Where is Samsung Biologics's headquarters?

    Samsung Biologics's headquarters is in Yeonsu-gu Incheon Gwang'yeogsi, KR
  2. How many employees does Samsung Biologics have?

    Samsung Biologics has 2,590 employees
  3. What sector does Samsung Biologics operate in?

    Samsung Biologics is in Biotechnology
  4. Who are Samsung Biologics's competitors?

    Samsung Biologics's top competitors are Sandoz, Celltrion, Dr.Reddy's